Efficacy of apamarga kshar internally in the management of hyperlipidemia

A randomized controlled clinical trial of efficacy of apamarga (achyranthes aspera) kshara internally in The management Of hyperlipidemia With special reference to medoroga

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052998

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients as per diagnostic criteria 2) Patients between age group 25-55 years 3) Patients of either gender 4) Irrespective of socioeconomic condition of patients

Exclusion criteria

Exclusion criteria: 1) Patients with renal impairments. 2) Patients already taking medicines for Hyperlipidemia 3) Patients having any other systemic disorders and complications. 4) Pregnant and lactating women. 5) Hyperlipidemia due to consumption of drugs e.g. Glucocorticoids. 6) Patients with pitta prakruti.

Design outcomes

Primary

Measure	Time frame
To study the efficacy ofApamarga kshara capsule in increased level of Sr cholesterol Sr LDL,Sr triglycerides,Sr VLDL Timepoint: 30 days	—

Secondary

Measure	Time frame
1) To study the effect of Apamarga kshara on BMI. 2) To study the preparation of kshara.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr PV Kulkarni

Goverment ayurvedic College nanded 431601

kulk.prasad1@gmail.com9405365096

Outcome results